2lnl: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2lnl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2lnl OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2lnl RCSB], [http://www.ebi.ac.uk/pdbsum/2lnl PDBsum]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2lnl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2lnl OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2lnl RCSB], [http://www.ebi.ac.uk/pdbsum/2lnl PDBsum]</span></td></tr> | ||
</table> | </table> | ||
== Function == | |||
[[http://www.uniprot.org/uniprot/CXCR1_HUMAN CXCR1_HUMAN]] Receptor to interleukin-8, which is a powerful neutrophils chemotactic factor. Binding of IL-8 to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activate a phosphatidylinositol-calcium second messenger system. This receptor binds to IL-8 with a high affinity and to MGSA (GRO) with a low affinity. | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||